賽象科技(002337.SZ):擬使用自有資金用於證券投資的最高額度為未到期累計餘額最高不超4億元
格隆匯3月11日丨賽象科技(002337.SZ)公佈,為充分提升公司資金使用效率及資金收益水平,增強公司盈利能力,公司第七屆董事會第二十五次會議審議通過了《關於使用閒置自有資金進行證券投資的議案》,公司在充分保障公司日常經營性資金需求、不影響公司正常生產經營並有效控制風險的前提下,擬使用自有資金用於證券投資的最高額度為未到期累計餘額最高不超過4億元人民幣,單筆不超過1.5億元人民幣。使用期限一年,該額度可以在有效期內循環使用。公司本次審議的證券投資額度將在去年審議的額度有效期限屆滿後正式生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.